KRAS and colorectal carcinoma: Jin et al. demonstrated that the ISAD assay detects KRAS G12D/G13D mutations in CRC within 30 min, with a detection limit of just 1% mutant alleles, outperforming PCR-based and direct sequencing approaches for rapid clinical decisions [193].